Skip to main content

PharVision Advisers, LLC

SEC CIK
0001898824
Latest filing
Aug 11, 2026

OPRX holding history

OptimizeRx Corp in every 13F filed by PharVision Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OPRX overviewAll 13F holders of OPRXFull Q2 2026 holdings

Shares (Q2 2026)
12,904
Value
$73.8K
% of portfolio
1.4%
Quarters held
1
Since Q2 2026
Holdings of OPRX by PharVision Advisers, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,904$73.8K1.4%+12,904NewHolders